Basel, 18 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Elecsys IL-6 immunoassay has become the first IL-6 test to have a certified claim for use in diagnosis of neonatal ...
Sepsis is the body's extreme response to an infection. It affects approximately 1.7 million adults in the United States each year and potentially contributes to more than 250,000 deaths. When ...
Clinical Infectious Diseases, Vol. 31, No. 6 (Dec., 2000), pp. 1338-1342 (5 pages) Monocyte phenotype, their phagocytic capacity as well as the cytokine production from 10 patients with sepsis with ...
Sepsis remains one of the leading causes of morbidity and mortality worldwide, and it is widely accepted that early recognition of the condition can seriously improve patient survival. A recent forum ...
Researchers at Atlanta-based Emory University and Beth Israel Deaconess Medical Center in Boston are launching two studies to test a treatment that could potentially cure the No. 1 cause of death in ...
SEPSIS can sometimes be difficult to recognise as symptoms are easily confused with common illnesses such as the flu. Delays in treatment for sepsis can be deadly and can result in organ damage and ...
The 2021 Surviving Sepsis Campaign Guidelines provided evidence-based recommendations for adult patients with sepsis and septic shock. This iteration of the guidelines placed increased emphasis on a ...
Neonatal sepsis is a leading cause of death for newborns Testing IL-6 can indicate a neonatal sepsis infection earlier than other biomarkers Earlier diagnosis of neonatal sepsis can lead to improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback